VIOXX and cardiovascular events: a class effect?

Joint Bone Spine. 2005 Jan;72(1):1-3. doi: 10.1016/j.jbspin.2004.11.001.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Diseases / chemically induced*
  • Cyclooxygenase Inhibitors / adverse effects*
  • Humans
  • Lactones / adverse effects*
  • Randomized Controlled Trials as Topic / methods*
  • Sulfones / adverse effects*

Substances

  • Cyclooxygenase Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib